The ratio of the S&P 500 dividend yield to the 10-year Treasury yield recently shifted from negative to positive, a historical indicator that often precedes major equity market downturns. This inflection, observed in October 2026, suggests a possible early warning for a decline in the S&P 500 within one to three months if the ratio maintains its positive trend. Capital tends to move into bonds before equity weakness becomes visible, making this shift less obvious in stock price charts. However, if the ratio reverses back, the signal for a downturn would be negated, so investors should watch this indicator closely for confirmation.
The ratio of the S&P 500 dividend yield to the US 10-year Treasury yield recently turned positive, signaling potential capital rotation. For readers following US stocks, here is Pluang's market snapshot as of Nov 11, 2026 00:02 WIB: out of 150 priced US stocks tradable on Pluang, 34 rose and 115 fell today. Notable movers include Barrick Gold Corp (USD 39.69, -6.10%, 9% Sell / 91% Buy), Kinross Gold Corporation (USD 21.53, -5.78%, 3% Sell / 97% Buy), and Novavax Inc (USD 10.27, -5.69%, 100% Sell / 0% Buy).
As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...
EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...
The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...
Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...
Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...
